Immutep (ASX:IMM) announces positive results in head and neck cancer treatment Peter Milios September 23, 2024 5:04 pm
Stocks of the Hour: Immutep, Lepidico, Mithril Silver and Gold Abbey Phillipps September 16, 2024 11:59 am
Immutep (ASX:IMM) reports first subject dosed in autoimmune disease study Peter Milios August 19, 2024 4:09 pm
Stocks of the Hour: Immutep, LiveHire, Forbidden Foods, Estrella Resources Peter Milios August 14, 2024 11:54 am
Clinical trials in cancer and autoimmune diseases: Immutep’s CEO Marc Voigt provides an update Manny Anton July 30, 2024 5:34 pm